Bain Capital Public Equity Management II’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-224,763
| Closed | -$2.38M | – | 34 |
|
|
2022
Q2 | $2.38M | Sell |
224,763
-295,436
| -57% | -$3.13M | 0.12% | 31 |
|
|
2022
Q1 | $8.46M | Sell |
520,199
-907,178
| -64% | -$14.7M | 0.27% | 29 |
|
|
2021
Q4 | $19.8M | Sell |
1,427,377
-45,094
| -3% | -$625K | 0.66% | 28 |
|
|
2021
Q3 | $21.2M | Sell |
1,472,471
-88,259
| -6% | -$1.27M | 0.74% | 27 |
|
|
2021
Q2 | $24.7M | Buy |
1,560,730
+842,000
| +117% | +$13.3M | 1.06% | 26 |
|
|
2021
Q1 | $7.31M | Buy |
+718,730
| New | +$7.31M | 0.3% | 43 |
|